Innovative Home Asthma Monitoring Solution
Lead Participant:
BREATHEOX LIMITED
Abstract
In the UK, every 10 seconds someone experiences a potentially life threatening Asthma attack, every 8 minutes someone is hospitalised and every 8 hours someone dies due to Asthma. These attacks cause significant morbidity and disruption to daily activities, besides burdening the NHS hundreds of millions in emergency healthcare costs. In the National Review of Asthma Deaths, it was found that patients often detect worsening symptoms late and the delay in prompt treatment contributed to many preventable deaths. Moreover, in the community, it is impossible for clinicians to assess the effectiveness of therapy for patients. While regular self-monitoring (using a symptom diary or breathing tests) is part of clinical guidance and shown to reduce asthma severity and risk of attacks, most patients report difficulty in adhering to manual monitoring every day. Passive physiological monitoring of asthma symptoms at home could flag early worsening and thus an asthma attack. We would like to develop, refine and validate an innovative monitoring technology that requires minimal patient interaction (thereby passive monitoring), and detects clinically useful measures, which can improve patient health by detecting worsening early.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| BREATHEOX LIMITED | £149,600 | £ 104,720 |
People |
ORCID iD |
| Mikesh Udani (Project Manager) |